flecainide and sotalol

flecainide has been researched along with sotalol in 117 studies

Research

Studies (117)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (4.27)	18.7374
1990's	33 (28.21)	18.2507
2000's	37 (31.62)	29.6817
2010's	28 (23.93)	24.3611
2020's	14 (11.97)	2.80

Authors

Authors	Studies
Baizman, ER; Becker, C; Bell, RH; Birsner, NC; Bohnet, EA; Busacca, CA; Carabateas, PM; Chadwick, CC; Gruett, MD; Johnson, RE	1
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Campillo, NE; Guerra, A; Páez, JA	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Glen, RC; Lowe, R; Mitchell, JB	1
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Barbey, JT; Solomon, AJ; Syn, D	1
Jung, W; Lüderitz, B; Manz, M	1
Camm, AJ; Gill, JS; Mehta, D; Ward, DE	1
Jouglard, J; Miller, AM; Moulin, M; Petitjean, J; Pisapia, A; Wagner, X	1
Crijns, HJ; Gosselink, AM; Hillege, H; Lie, KI; Van Gelder, IC; Van Gilst, WH	1
Cheymol, G; Chézalviel, F; Davy, JM; Engel, F; Ertzbischoff, O; Lainée, P; Motté, G; Penin, E; Poirier, JM; Weissenburger, J	1
Camm, AJ; Garratt, CJ; Griffith, MJ; Linker, NJ; Ward, DE	1
Anderson, JL	1
Gössinger, HD; Mösslacher, H; Siostrzonek, P	1
Hamer, A; Hunt, D; Vohra, J; Warren, R	1
Bettini, R; Cozzi, F; Dal Forno, P; Furlanello, F	1
Hoffman, BF; Spinelli, W	1
Engel, T; Kelliher, GJ; Kowey, P; Wetstein, L	1
Huang, SK; Marcus, FI	1
Gomoll, AW	1
Atallah, G; Kirkorian, G; Moleur, P; Touboul, P	1
Aiyar, J; Auperin, DD; Chandy, KG; Grissmer, S; Gutman, GA; Hanson, DC; Karmilowicz, MJ; Mather, RJ; Nguyen, AN	1
McCarthy, PT; O'Sullivan, JJ; Wren, C	1
Burattini, M; Carunchio, A; Ceci, V; Fera, MS; Galati, A; Greco, G; Mazza, A	1
Inoue, H; Saihara, S; Sugimoto, T; Usui, M	1
Gonzalez, MD; Kidwell, GA	1
Hamer, AW; Hunt, VD; Strathmore, N; Vohra, JK	1
Chalmers, JP; McRitchie, RJ; Roberts-Thomson, P; Twidale, N	1
Gutiérrez-Larraya, F; Jabón, A	1
Lüderitz, B; Manz, M	1
Brechenmacher, C; Chauvin, M; Koenig, A; Theolade, R	1
Beukema, WP; Defauw, JJ; Hoogteijling-van Dusseldorp, E; Kelder, JC; Kingma, JH; van Hemel, NM; Vermeulen, FE	1
DiMarco, JP; Jung, F	1
Briglia, N; Ducceschi, V; Esposito, R; Iacono, A; Mayer, MS; Santangelo, L; Sarubbi, B; Scialdone, A	1
Burattini, M; Carunchio, A; Ceci, V; Coletta, C; Fera, MS; Galati, A; Mazza, A	1
Kuhn, RJ; Luedtke, SA; McCaffrey, FM	1
Borggrefe, M; Breithardt, G; Eckardt, L; Göttker, U; Haverkamp, W; Johna, R; Madeja, M	1
Ebner, A; Gatterer, E; Gattermeier, M; Heinze, G; Hohenwallner, W; Kratzer, H; Kuhn, P; Lenz, K; Poelzl, G; Reisinger, J; Slany, J; Wiesinger, K; Zeindlhofer, E	1
Braat, SH; Heymeriks, J; Peters, FP; Wellens, HJ	1
Briglia, N; Ducceschi, V; Iacono, A; Mayer, MS; Santangelo, L; Sarubbi, B	1
Allessie, MA; Dorland, R; Wijffels, MC	1
Brügemann, J; Crijns, HJ; De Kam, PJ; Tuinenburg, AE; Van Den Berg, MP; Van Gelder, IC	1
Cánoves, J; Chorro, FJ; Guerrero, J; López-Merino, V; Mainar, L; Sanchis, J; Such, L	1
Dell'Orfano, JT; Luck, JC; Naccarelli, GV; Patel, HM; Wolbrette, DL	1
Allessie, MA; Dorland, R; Mast, F; Wijffels, MC	1
Aass, H; Kongsgaard, E	1
Kanmatuse, K; Kojima, T; Kunimoto, S; Masaki, R; Nakai, T; Oshikawa, N; Ozawa, Y; Saito, S; Watanabe, H; Watanabe, I	1
Ambachtsheer, EB; Meijboom, EJ; Oudijk, MA; Stoutenbeek, P	1
Fenrich, AL; Friedman, RA; Kertesz, NJ; Price, JF; Snyder, CS	1
Bacchi Reggiani, L; Bartolotti, M; Biffi, M; Boriani, G; Branzi, A; Zannoli, R	1
Alboni, P; Bongiorni, MG; Botto, GL; Brignole, M; Bruna, C; Gasparini, M; Menozzi, C; Ometto, R; Verlato, R; Vincenti, A	1
Brouwers, JR; Deneer, VH; Drese, GB; Junginger, HE; Kingma, JH; Lie-A-Huen, L; Roemelé, PE; Verhoef, JC	1
Bhatta, L; Hynes, J; Khan, M; Luck, J; Naccarelli, GV; Samii, S; Wolbrette, DL	1
Delahaye, S; Dommergues, M; Dumez, Y; Fermont, L; Jouannic, JM; Le Bidois, J; Villain, E	1
Mounsey, JP; VerNooy, RA	1
Antzelevitch, C; Bianchi, F; Borggrefe, M; Brugada, R; Calò, L; Gaita, F; Giustetto, C; Haissaguerre, M; Schimpf, R; Wolpert, C	1
Bleich, M; Brendel, J; Busch, AE; Knobloch, K; Rosenstein, B; Wirth, KJ	1
Dorian, P; Humphries, KH; Kerr, CR; Steinbuch, M	1
Annunziata, A; Calabrò, R; Cardaropoli, D; D'Alto, M; Pacileo, G; Paladini, D; Romeo, E; Russo, MG; Sarubbi, B	1
Breithardt, G; Eckardt, L; Engelen, M; Franz, MR; Haverkamp, W; Kirchhof, P; Ribbing, M; Wasmer, K	1
Allessie, M; Blaauw, Y; Duytschaever, M	1
Scharf, C	1
Akhtar, M; Narayan, G; Sra, J	1
Crijns, HJ; Hagens, VE; Rienstra, M; Van Gelder, IC; Van Veldhuisen, DJ	1
Augello, G; Greiss, I; Gugliotta, F; Gulletta, S; LiVolsi, L; Manguso, F; Mazzone, P; Paglino, G; Pappone, C; Pappone, N; Radinovic, A; Sala, S; Santagostino, A; Santinelli, V; Sora, N; Vicedomini, G	1
Fodstad, H; Kontula, K; Laitinen-Forsblom, P; Lehtonen, A; Swan, H; Toivonen, L	1
Bauman, JL; Kehoe, RF; Leal, S; Mykytsey, A; Razminia, M; Saleem, M; Wang, T; Zheutlin, T	1
Borggrefe, M; Breithardt, G; Eckardt, L; Milberg, P; Osada, N; Schimpf, R; Tegelkamp, R; Wolpert, C	1
Kaufman, ES	1
Boriani, G; Chiarandà, G; Colletti, A; Di Giovanni, N; Grammatico, A; Gulizia, M; Lisi, F; Mangiameli, S; Orazi, S; Pensabene, O; Piccione, G; Vasquez, L	1
Liakishev, AA	1
Accord, RE; Allessie, MA; Hermans, JJ; Maessen, JG; Schotten, U; Smits, JF; van Brakel, TJ	1
Breithardt, G; Camm, J; Crijns, H; Dorian, P; Kowey, PR; Le Heuzey, JY; Pedrazzini, L; Prystowsky, EN; Salette, G; Schwartz, PJ; Torp-Pedersen, C; Weintraub, W	1
Hobbs, FD; Hodgkinson, J; Taylor, CJ	1
Eckert, L; Freemantle, N; Lafuente-Lafuente, C; Mitchell, S; Reynolds, M	1
Kong, DF; Piccini, JP	1
Api, O; Blom, NA; Carvalho, JS; Clur, SA; De Groot, E; Jaeggi, ET; Manlhiot, C; McCrindle, BW; Rammeloo, L; Ryan, G	1
Alegret, JM; Freire, F; Romero-Menor, C; Viñolas, X	1
Belardinelli, L; Breithardt, G; Eckardt, L; Frommeyer, G; Ghezelbash, S; Milberg, P; Osada, N; Rajamani, S; Razvan, R	1
Gjesdal, K; Graff-Iversen, S; Jugessur, A; Nystad, W; Sakshaug, S; Selmer, R; Thelle, DS; Tverdal, A	1
Ermakov, S; Gerstenfeld, EP; Hoffmayer, KS; Scheinman, MM	1
Al-Khatib, SM; Allen LaPointe, NM; Dai, D; Peterson, ED; Piccini, JP; Thomas, L	1
Ector, J; Gallacher, DJ; Garweg, C; Janssens, S; Lu, HR; Nuyens, D; Robyns, T; Willems, R	1
Ahsan, SY; Di Mario, C; Hayward, C; Lyon, AR; Patel, HC; Patel, K; Rowland, E	1
Ermakov, S; Gerstenfeld, EP; Scheinman, MM; Svetlichnaya, Y	1
Frommelt, MA; Hill, GD; Kovach, JR; Saudek, DE; Singh, AK; Wehrheim, K	1
Hagiwara, A; Hamasaki, T; Horigome, H; Ikeda, T; Inamura, N; Kato, H; Katsuragi, S; Kawataki, M; Maeno, Y; Miyoshi, T; Nii, M; Sago, H; Sakaguchi, H; Shimizu, W; Shiraishi, I; Shozu, M; Taketazu, M; Ueda, K; Yamamoto, H; Yasukochi, S; Yoda, H	1
Dai, W; Gandhi, S; Juhaeri, J; Kechemir, H; Lin, S; Tcherny-Lessenot, S; Wang, Y; Wu, C	1
Friberg, L	1
Nakayashiro, M; Sakurai, K; Takahashi, K	1
Hinoi, E; Miyawaki, I; Tsubouchi, T; Watanabe, K; Yamada, T	1
Hagiwara, A; Hamasaki, T; Horigome, H; Ikeda, T; Inamura, N; Kato, H; Katsuragi, S; Kawataki, M; Maeno, Y; Miyoshi, T; Nii, M; Sago, H; Sakaguchi, H; Shimizu, W; Shiraishi, I; Taketazu, M; Ueda, K; Yamamoto, H; Yasukochi, S; Yoda, H	1
Andrews, LM; Koch, BCP; van der Nagel, BCH; van Domburg, B	1
Abutaqa, M; Arabi, M; Bitar, F; El Dick, J; Refaat, M; Sabra, M; Tayeh, C	1
Abraham, V; Ahmed, M; Alamar, I; Alzahrani, Z; Chen, Y; Darbar, D; Darbar, FA; Hong, L; Kany, S; Konda, S; Menon, A; Ornelas-Loredo, A; Sridhar, A; Zhang, M	1
Acharya, G; Sonesson, SE	1
Adiyaman, A; Beukema, RJ; de Jong, JSSG; Delnoy, PPHM; Elvan, A; Haanschoten, DM; Khan, M; Otten, AM; Ramdat Misier, AR; Smit, JJJ; Szili-Torok, T; Ter Bekke, RMA; Vernooy, K	1
Bertels, RA; Blom, NA; Filippini, LH; Kammeraad, JAE; Knobbe, I; Kuipers, IM; Zeelenberg, AM	1
Belli, G; Brambilla, A; Capponi, G; De Simone, L; Favilli, S; Giovannini, M; Porcedda, G; Remaschi, G; Vannuccini, F	1
D'Angelo, RN; Goldstein, L; Kalsekar, I; Khanna, R; Rahman, M; Tung, P; Yadalam, S; Yeh, RW; Zimetbaum, PJ	1
Kahr, PC; Kim, JJ; Miyake, CY; Moffett, BS; Valdes, SO	1
Badenco, N; Duthoit, G; Frank, R; Gandjbakhch, E; Hidden-Lucet, F; Himbert, C; Laredo, M; Maupain, C; Rolland, T; Waintraub, X	1
Briller, JE; Elkayam, U; Lakkireddy, DR; Mason, PK; Merchant, FM; Patel, H; Pillarisetti, J; Russo, AM; Tamirisa, KP; Vaseghi, M; Volgman, AS	1
Kawai, T; Kuninishi, Y; Muraki, Y; Nogawa, H	1
Bhatia, NK; De Lurgio, DB; El-Chami, MF; Ibrahim, R; Kiani, S; Leon, AR; Lloyd, MS; Merchant, FM; Patel, AM; Sayegh, MN; Shah, AD; Thompkins, CM; Westerman, SB	1
Chung, CP; Daugherty, JR; Dickson, AL; Dupont, WD; Hung, AM; Murray, KT; Ray, WA; Smalley, W; Stein, CM; Zimmerman, E	1
Bukumirić, Z; Jurčević, R; Kojić, D; Marić, M; Radunović, A; Rajsic, S; Sušić, M; Tomović, M; Žugić, V	1

Reviews

21 review(s) available for flecainide and sotalol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias. The American journal of cardiology, 1990, Jan-16, Volume: 65, Issue:4 Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Heart Ventricles; Humans; Risk Factors; Sotalol; Ventricular Fibrillation	1990
Clinical pharmacology of antiarrhythmic agents. Cardiovascular clinics, 1985, Volume: 16, Issue:1 Topics: Adrenergic beta-Antagonists; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Calcium Channel Blockers; Electrophysiology; Encainide; Flecainide; Heart Conduction System; Humans; Lidocaine; Moricizine; Phenothiazines; Piperidines; Quaternary Ammonium Compounds; Sotalol; Tocainide	1985
Antiarrhythmic drug therapy of ventricular arrhythmias. Current problems in cardiology, 1986, Volume: 11, Issue:4 Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil	1986
[New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol]. Annales de cardiologie et d'angeiologie, 1982, Volume: 31, Issue:7 Topics: Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Electrophysiology; Encainide; Flecainide; Hemodynamics; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Sotalol; Tocainide	1982
[Tachycardias: considerations in childhood in the 90s]. Anales espanoles de pediatria, 1993, Volume: 39, Issue:6 Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiography; Ergometry; Flecainide; Heart; Heart Ventricles; Humans; Infant; Infant, Newborn; Lidocaine; Middle Aged; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Tachycardia, Ventricular	1993
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy. European heart journal, 1993, Volume: 14 Suppl E Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil	1993
[Antiarrhythmic treatment after reduction of atrial fibrillation by external shock]. Presse medicale (Paris, France : 1983), 1993, Nov-20, Volume: 22, Issue:36 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Disopyramide; Electric Countershock; Flecainide; Humans; Propafenone; Quinidine; Recurrence; Sotalol	1993
Antiarrhythmic drug therapy in the treatment of atrial fibrillation. Cardiology clinics, 1996, Volume: 14, Issue:4 Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Electrophysiology; Flecainide; Humans; Ion Channels; Quinidine; Sotalol; Sulfonamides	1996
Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry. The Annals of pharmacotherapy, 1997, Volume: 31, Issue:10 Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium Channel Blockers; Child; Child, Preschool; Digoxin; Flecainide; Humans; Infant; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Wolff-Parkinson-White Syndrome	1997
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy. The American journal of cardiology, 2000, May-25, Volume: 85, Issue:10A Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Echocardiography, Transesophageal; Electric Countershock; Flecainide; Humans; Procainamide; Propafenone; Quinidine; Sotalol; Verapamil	2000
Management of atrial flutter. Current cardiology reports, 2000, Volume: 2, Issue:4 Topics: Animals; Anti-Arrhythmia Agents; Atrial Flutter; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Flecainide; Heart Conduction System; Humans; Quality of Life; Recurrence; Sotalol; Treatment Outcome	2000
[Protocols for the treatment of supraventricular tachycardias in the fetus]. Nederlands tijdschrift voor geneeskunde, 2001, Jun-23, Volume: 145, Issue:25 Topics: Anti-Arrhythmia Agents; Atrial Flutter; Clinical Protocols; Digoxin; Drug Therapy, Combination; Female; Fetal Diseases; Flecainide; Humans; Hydrops Fetalis; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Sotalol; Tachycardia, Supraventricular	2001
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. The American journal of cardiology, 2003, Mar-20, Volume: 91, Issue:6A Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Canada; Controlled Clinical Trials as Topic; Europe; Flecainide; Heart Conduction System; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Propafenone; Quinidine; Sotalol; Sulfonamides; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; United States	2003
Antiarrhythmic drug therapy of atrial fibrillation. Cardiology clinics, 2004, Volume: 22, Issue:1 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Flecainide; Humans; Phenethylamines; Sotalol; Sulfonamides	2004
[Atrial flutter and fibrillation]. Praxis, 2005, Nov-09, Volume: 94, Issue:45 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; Clinical Trials as Topic; Disopyramide; Electric Countershock; Electrocardiography; Emergencies; Flecainide; Heart Rate; Humans; Middle Aged; Pacemaker, Artificial; Propafenone; Quinidine; Recurrence; Sotalol; Sulfonamides; Treatment Outcome; Vasodilator Agents	2005
Quinidine in short QT syndrome: an old drug for a new disease. Journal of cardiovascular electrophysiology, 2007, Volume: 18, Issue:6 Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Electrocardiography; Electrophysiologic Techniques, Cardiac; Flecainide; Genetic Predisposition to Disease; Humans; Quinidine; Rabbits; Sotalol; Treatment Outcome	2007
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011, Volume: 13, Issue:3 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Randomized Controlled Trials as Topic; Sotalol; Treatment Outcome	2011
Transplacental treatment of fetal tachycardia: A systematic review and meta-analysis. Prenatal diagnosis, 2017, Volume: 37, Issue:11 Topics: Anti-Arrhythmia Agents; Digoxin; Female; Fetal Diseases; Fetal Therapies; Flecainide; Humans; Pregnancy; Sotalol; Tachycardia	2017
Sotalol as an effective adjunct therapy in the management of supraventricular tachycardia induced fetal hydrops fetalis. Journal of neonatal-perinatal medicine, 2020, Volume: 13, Issue:2 Topics: Adult; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Female; Fetal Diseases; Flecainide; Humans; Hydrops Fetalis; Pregnancy; Sotalol; Tachycardia, Supraventricular; Young Adult	2020
Arrhythmias in Pregnancy. JACC. Clinical electrophysiology, 2022, Volume: 8, Issue:1 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Flecainide; Humans; Pregnancy; Sotalol; Tachycardia	2022

Trials

18 trial(s) available for flecainide and sotalol

Article	Year
Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia. Lancet (London, England), 1990, Sep-15, Volume: 336, Issue:8716 Topics: Adenosine; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Clinical Trials as Topic; Disopyramide; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Flecainide; Humans; Hypotension; Injections, Intravenous; Lidocaine; Middle Aged; Recurrence; Sotalol; Tachycardia	1990
[A comparison between flecainide and sotalol in the prevention of recurrences of paroxysmal atrial fibrillation]. Giornale italiano di cardiologia, 1995, Volume: 25, Issue:1 Topics: Adult; Aged; Atrial Fibrillation; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Recurrence; Risk Factors; Sotalol; Time Factors	1995
Oral flecainide, sotalol, and verapamil for the termination of paroxysmal supraventricular tachycardia. Pacing and clinical electrophysiology : PACE, 1993, Volume: 16, Issue:7 Pt 1 Topics: Administration, Oral; Adult; Cardiac Pacing, Artificial; Female; Flecainide; Humans; Male; Middle Aged; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil	1993
Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia. European heart journal, 1996, Volume: 17, Issue:4 Topics: Adult; Aged; Anti-Arrhythmia Agents; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Sotalol; Survival Analysis; Tachycardia, Ventricular; Treatment Failure	1996
[Comparison of anti-arrhythmic therapy guided by the transesophageal electropharmacologic test and emperic therapy in the prophylaxis of atrial fibrillation recurrence]. Giornale italiano di cardiologia, 1997, Volume: 27, Issue:2 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography, Transesophageal; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Recurrence; Sotalol	1997
Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation. The American journal of cardiology, 1998, Jun-15, Volume: 81, Issue:12 Topics: Age Factors; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Administration Schedule; Female; Flecainide; Humans; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Prospective Studies; Sex Factors; Single-Blind Method; Sotalol; Time Factors; Treatment Outcome	1998
Treatment of recent onset atrial fibrillation with intravenous sotalol and/or flecainide. The Netherlands journal of medicine, 1998, Volume: 53, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combination; Electric Countershock; Female; Flecainide; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Prognosis; Prospective Studies; Sotalol; Treatment Outcome	1998
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. European heart journal, 2002, Volume: 23, Issue:11 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Catheter Ablation; Echocardiography; Female; Flecainide; Follow-Up Studies; Humans; Male; Pacemaker, Artificial; Propafenone; Prospective Studies; Quality of Life; Sotalol; Time Factors	2002
Short QT syndrome: pharmacological treatment. Journal of the American College of Cardiology, 2004, Apr-21, Volume: 43, Issue:8 Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography; Female; Flecainide; Humans; Male; Quinidine; Sotalol; Syndrome; Treatment Outcome	2004
Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation. Basic research in cardiology, 2005, Volume: 100, Issue:2 Topics: Action Potentials; Adult; Aged; Anti-Arrhythmia Agents; Atrial Appendage; Atrial Fibrillation; Electric Countershock; Female; Flecainide; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Potassium Channel Blockers; Refractory Period, Electrophysiological; Secondary Prevention; Sodium Channel Blockers; Sotalol; Time Factors; Treatment Outcome	2005
Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study. The American journal of cardiology, 2006, Oct-01, Volume: 98, Issue:7 Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Death, Sudden, Cardiac; Diabetes Mellitus; Digitalis Glycosides; Electric Countershock; Fatigue; Female; Flecainide; Follow-Up Studies; Humans; Male; Myocardial Infarction; Netherlands; Proportional Hazards Models; Risk Factors; Secondary Prevention; Sotalol	2006
A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. Journal of the American College of Cardiology, 2006, Dec-05, Volume: 48, Issue:11 Topics: Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Catheter Ablation; Dose-Response Relationship, Drug; Female; Flecainide; Follow-Up Studies; Hospitalization; Humans; Hypertension; Kaplan-Meier Estimate; Male; Medical Records; Middle Aged; Prognosis; Pulmonary Veins; Retreatment; Sotalol; Stroke Volume; Treatment Failure	2006
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function. Journal of cardiovascular pharmacology and therapeutics, 2007, Volume: 12, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Monitoring; Female; Flecainide; Follow-Up Studies; Humans; Inpatients; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Propafenone; Recurrence; Sotalol; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left; Withholding Treatment	2007
A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA American heart journal, 2008, Volume: 155, Issue:1 Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Follow-Up Studies; Humans; Male; Probability; Propafenone; Prospective Studies; Reference Values; Risk Assessment; Single-Blind Method; Sotalol; Statistics, Nonparametric; Survival Rate; Treatment Outcome	2008
[Circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation. Results of the APAF trial]. Kardiologiia, 2008, Volume: 48, Issue:4 Topics: Adolescent; Adult; Aged; Amiodarone; Angina, Unstable; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Flecainide; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Pulmonary Veins; Sotalol; Tachycardia, Paroxysmal; Treatment Outcome	2008
Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey. Clinical cardiology, 2010, Volume: 33, Issue:3 Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Cardiac Glycosides; Cardiotonic Agents; Clinical Competence; Female; Flecainide; Health Care Surveys; Health Knowledge, Attitudes, Practice; Heart Rate; Humans; Internationality; Male; Middle Aged; Practice Guidelines as Topic; Propafenone; Prospective Studies; Registries; Sotalol; Surveys and Questionnaires	2010
Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial. Journal of the American College of Cardiology, 2019, 08-20, Volume: 74, Issue:7 Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Atrial Flutter; Cesarean Section; Digoxin; Female; Fetal Death; Fetal Diseases; Flecainide; Humans; Infant, Newborn; Injections, Intravenous; Japan; Natriuretic Peptide, Brain; Pregnancy; Pregnancy Complications; Premature Birth; Prenatal Care; Recurrence; Sotalol; Tachycardia; Tachycardia, Supraventricular; Umbilical Veins; Young Adult	2019
Elimination of Benign Ventricular Premature Beats or Ventricular Tachycardia with Catheter Ablation versus Two Different Optimal Antiarrhythmic Drug Treatment Regimens (Sotalol or Verapamil/Flecainide). Cardiology, 2020, Volume: 145, Issue:12 Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Catheter Ablation; Flecainide; Humans; Prospective Studies; Quality of Life; Sotalol; Tachycardia, Ventricular; Treatment Outcome; Verapamil	2020

Other Studies

78 other study(ies) available for flecainide and sotalol

Article	Year
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents. Journal of medicinal chemistry, 1993, Oct-29, Volume: 36, Issue:22 Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium Channels; Structure-Activity Relationship	1993
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds. Journal of medicinal chemistry, 2001, Jul-19, Volume: 44, Issue:15 Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water	2001
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
MICE models: superior to the HERG model in predicting Torsade de Pointes. Scientific reports, 2013, Volume: 3 Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
A simple in vivo model to evaluate the effects of antiarrhythmic agents. Pacing and clinical electrophysiology : PACE, 1992, Volume: 15, Issue:11 Pt 2 Topics: Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Pacing, Artificial; Catheter Ablation; Dogs; Electrocardiography; Flecainide; Heart Block; Heart Conduction System; Male; Sotalol	1992
[Combination anti-arrhythmic drug therapy]. Zeitschrift fur Kardiologie, 1992, Volume: 81 Suppl 4 Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography, Ambulatory; Encainide; Flecainide; Humans; Mexiletine; Sotalol; Tachycardia; Tocainide	1992
Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality. British heart journal, 1992, Volume: 68, Issue:4 Topics: Adult; Aged; Electric Stimulation; Exercise Test; Flecainide; Humans; Male; Middle Aged; Sotalol; Tachycardia, Ventricular; Treatment Outcome; Verapamil	1992
Coadministration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta, and excretion in human breast milk. American heart journal, 1990, Volume: 119, Issue:3 Pt 1 Topics: Adult; Cardiac Complexes, Premature; Drug Therapy, Combination; Female; Flecainide; Humans; Maternal-Fetal Exchange; Milk, Human; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Sotalol; Tachycardia	1990
Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. The American journal of cardiology, 1991, Aug-01, Volume: 68, Issue:4 Topics: Actuarial Analysis; Aged; Amiodarone; Analysis of Variance; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Drug Administration Schedule; Electric Countershock; Female; Flecainide; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Quinidine; Recurrence; Sotalol	1991
Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol. The Journal of pharmacology and experimental therapeutics, 1991, Volume: 259, Issue:2 Topics: Animals; Anti-Arrhythmia Agents; Bradycardia; Consciousness; Diuretics; Dogs; Electrocardiography, Ambulatory; Electrolytes; Electrophysiology; Female; Flecainide; Heart Block; Hypocalcemia; Lidocaine; Male; Propranolol; Quinidine; Sotalol	1991
Combined sotalol and flecainide given at low dosage in patients with the Wolff-Parkinson-White syndrome. International journal of cardiology, 1990, Volume: 26, Issue:3 Topics: Adult; Drug Combinations; Female; Flecainide; Follow-Up Studies; Humans; Male; Refractory Period, Electrophysiological; Sotalol; Wolff-Parkinson-White Syndrome	1990
Serious interactions of sotalol with amiodarone and flecainide. The Medical journal of Australia, 1990, Mar-05, Volume: 152, Issue:5 Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Flecainide; Humans; Hypotension; Male; Middle Aged; Sotalol	1990
Arrhythmogenic effects of antiarrhythmic drugs. Cardiologia (Rome, Italy), 1990, Volume: 35, Issue:1 Suppl Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Risk Factors; Sotalol; Tachycardia; Verapamil	1990
Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents. Circulation research, 1989, Volume: 65, Issue:6 Topics: Animals; Anti-Arrhythmia Agents; Disopyramide; Dogs; Electrocardiography; Flecainide; Heart Conduction System; Heart Rate; Lidocaine; Piperidines; Propafenone; Sotalol	1989
Assessment of drug effects on spontaneous and induced ventricular arrhythmias in a 24-h canine infarction model. Arzneimittel-Forschung, 1987, Volume: 37, Issue:7 Topics: Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Dogs; Electrocardiography; Encainide; Female; Flecainide; Male; Myocardial Infarction; Sotalol	1987
Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Molecular pharmacology, 1994, Volume: 45, Issue:6 Topics: 3T3 Cells; Animals; Base Sequence; Benzopyrans; Capsaicin; Cell Line; Cells, Cultured; Charybdotoxin; Cloning, Molecular; Cromakalim; Diltiazem; Diterpenes; Elapid Venoms; Flecainide; Ion Channel Gating; Mice; Molecular Sequence Data; Nifedipine; Oligodeoxyribonucleotides; Peptides; Potassium Channels; Pyrroles; Scorpion Venoms; Sotalol	1994
Differences in amiodarone, digoxin, flecainide and sotalol concentrations between antemortem serum and femoral postmortem blood. Human & experimental toxicology, 1995, Volume: 14, Issue:7 Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Femoral Artery; Femoral Vein; Flecainide; Humans; Male; Postmortem Changes; Sotalol	1995
Antifibrillatory effects of class III antiarrhythmic drugs: comparative study with flecainide. Journal of cardiovascular pharmacology, 1993, Volume: 21, Issue:3 Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Dogs; Electric Stimulation; Flecainide; Heart Conduction System; Piperidines; Pyridines; Sotalol; Ventricular Fibrillation	1993
Effects of flecainide and D-sotalol on myocardial conduction and refractoriness: relation to antiarrhythmic and proarrhythmic drug effects. Journal of cardiovascular pharmacology, 1993, Volume: 21, Issue:4 Topics: Animals; Arrhythmias, Cardiac; Dogs; Electric Stimulation; Electrocardiography; Electrophysiology; Female; Flecainide; Heart; Heart Conduction System; Male; Myocardial Infarction; Sotalol	1993
Comparative haemodynamic effects of verapamil, flecainide, amiodarone and sotalol in the conscious rabbit. Clinical and experimental pharmacology & physiology, 1994, Volume: 21, Issue:3 Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Autonomic Nerve Block; Autonomic Nervous System; Cardiac Output; Cardiac Pacing, Artificial; Consciousness; Flecainide; Heart; Heart Atria; Heart Rate; Hemodynamics; Male; Rabbits; Sotalol; Verapamil	1994
[Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy]. Cardiologia (Rome, Italy), 1996, Volume: 41, Issue:7 Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Child; Electrocardiography; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Retrospective Studies; Sotalol; Ventricular Function	1996
Divergent effect of acute ventricular dilatation on the electrophysiologic characteristics of d,l-sotalol and flecainide in the isolated rabbit heart. Journal of cardiovascular electrophysiology, 1998, Volume: 9, Issue:4 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dilatation, Pathologic; Electrocardiography; Flecainide; Heart Conduction System; Hemodynamics; Male; Rabbits; Reproducibility of Results; Sotalol; Ventricular Dysfunction, Left; Ventricular Fibrillation	1998
Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease. International journal of cardiology, 1998, Sep-30, Volume: 66, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Child; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Male; Middle Aged; Propafenone; Sotalol; Ventricular Function	1998
Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol. Journal of cardiovascular electrophysiology, 1999, Volume: 10, Issue:2 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Disease Models, Animal; Electrocardiography; Flecainide; Follow-Up Studies; Goats; Heart Conduction System; Imidazoles; Injections, Intravenous; Quinidine; Secondary Prevention; Sotalol; Treatment Outcome	1999
Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation. Heart (British Cardiac Society), 1999, Volume: 82, Issue:4 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Electric Countershock; Female; Flecainide; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Risk; Sotalol; Treatment Failure; Warfarin	1999
Alteration of ventricular fibrillation by flecainide, verapamil, and sotalol: an experimental study. Circulation, 2000, Apr-04, Volume: 101, Issue:13 Topics: Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrophysiology; Flecainide; Heart Conduction System; Rabbits; Refractory Period, Electrophysiological; Sotalol; Ventricular Fibrillation; Verapamil	2000
Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation, 2000, Jul-11, Volume: 102, Issue:2 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Flecainide; Goats; Heart Conduction System; Imidazoles; Quinidine; Sotalol	2000
Frequency-dependent electrophysiological effects of flecainide, nifekalant and d,l-sotalol on the human atrium. Japanese circulation journal, 2001, Volume: 65, Issue:1 Topics: Action Potentials; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Cohort Studies; Drug Evaluation; Electrophysiologic Techniques, Cardiac; Flecainide; Heart Atria; Humans; Middle Aged; Pyrimidinones; Sotalol	2001
Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age. Journal of the American College of Cardiology, 2002, Feb-06, Volume: 39, Issue:3 Topics: Anti-Arrhythmia Agents; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Female; Flecainide; Follow-Up Studies; Heart Rate; Humans; Infant; Infant Welfare; Infant, Newborn; Male; Recurrence; Sotalol; Tachycardia, Supraventricular; Texas; Treatment Outcome; Ventricular Function, Left; Wolff-Parkinson-White Syndrome	2002
Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. Heart (British Cardiac Society), 2002, Volume: 87, Issue:5 Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Electrocardiography; Electrophysiology; Female; Flecainide; Humans; Male; Middle Aged; Recurrence; Regression Analysis; Sotalol; Treatment Outcome; Ventricular Dysfunction, Left	2002
Buccal transport of flecainide and sotalol: effect of a bile salt and ionization state. International journal of pharmaceutics, 2002, Jul-08, Volume: 241, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Bile Acids and Salts; Cheek; Chromatography, High Pressure Liquid; Flecainide; Glycocholic Acid; Hydrogen-Ion Concentration; In Vitro Techniques; Mouth Mucosa; Permeability; Pharmaceutical Solutions; Sotalol; Swine	2002
[Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases]. Journal de gynecologie, obstetrique et biologie de la reproduction, 2003, Volume: 32, Issue:4 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Clinical Protocols; Digoxin; Echocardiography; Female; Fetal Diseases; Flecainide; Gestational Age; Heart Rate, Fetal; Humans; Hydrops Fetalis; Infant, Newborn; Pregnancy; Pregnancy Outcome; Prenatal Care; Retrospective Studies; Sotalol; Tachycardia, Ectopic Junctional; Tachycardia, Supraventricular; Treatment Outcome; Ultrasonography, Prenatal	2003
Atrial fibrillation: rate control often better than rhythm control. Prescrire international, 2004, Volume: 13, Issue:70 Topics: Adult; Aged; Amiodarone; Anticoagulants; Arrhythmia, Sinus; Atrial Fibrillation; Canada; Disopyramide; Electric Countershock; Flecainide; Heart Rate; Humans; Netherlands; Platelet Aggregation Inhibitors; Propafenone; Quinidine; Sotalol; United States	2004
Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs. Medical science monitor : international medical journal of experimental and clinical research, 2004, Volume: 10, Issue:7 Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Atropine; Biphenyl Compounds; Chromans; Flecainide; Heart Atria; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Potassium Channel Blockers; Potassium Channels; Propafenone; Propanolamines; Sotalol; Sulfonamides; Swine; Ventricular Function	2004
Limitations to antiarrhythmic drug use in patients with atrial fibrillation. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2004, Sep-28, Volume: 171, Issue:7 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Contraindications; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Quinidine; Registries; Sotalol	2004
Fetal supraventricular tachycardia diagnosed and treated at twenty-four weeks of gestation and after birth: a case report. Italian heart journal : official journal of the Italian Federation of Cardiology, 2004, Volume: 5, Issue:10 Topics: Adult; Anti-Arrhythmia Agents; Digoxin; Female; Fetal Distress; Flecainide; Gestational Age; Humans; Maternal-Fetal Exchange; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Sotalol; Tachycardia, Supraventricular; Ultrasonography, Prenatal	2004
Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs. Cardiovascular research, 2005, Jul-01, Volume: 67, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Electric Countershock; Electrophysiology; Flecainide; Goats; Models, Animal; Random Allocation; Refractory Period, Electrophysiological; Sotalol; Sulfonamides; Treatment Failure; Ventricular Remodeling	2005
Combined use of 1C and III agents for highly symptomatic, refractory atrial fibrillation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2006, Volume: 15, Issue:3 Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Drug Combinations; Female; Flecainide; Humans; Male; Middle Aged; Phenethylamines; Propafenone; Secondary Prevention; Sotalol; Sulfonamides; Treatment Failure; Treatment Outcome	2006
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes. Heart rhythm, 2007, Volume: 4, Issue:5 Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; DNA Mutational Analysis; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Finland; Flecainide; Founder Effect; Genetic Predisposition to Disease; Genetic Testing; Heart Conduction System; Humans; KCNQ1 Potassium Channel; Long QT Syndrome; Male; Middle Aged; Mutation; Propafenone; Risk Factors; Sotalol; Torsades de Pointes; Treatment Outcome	2007
Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. Journal of cardiovascular electrophysiology, 2007, Volume: 18, Issue:6 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Flecainide; Heart Conduction System; In Vitro Techniques; Pinacidil; Quinidine; Rabbits; Random Allocation; Refractory Period, Electrophysiological; Sotalol; Vasodilator Agents	2007
Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation. Journal of cardiovascular electrophysiology, 2009, Volume: 20, Issue:2 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Stimulation; Electrocardiography; Electrophysiology; Flecainide; Goats; Heart Atria; Injections; Injections, Intravenous; Pericardium; Sotalol	2009
Rhythm control agents and adverse events in patients with atrial fibrillation. International journal of clinical practice, 2010, Volume: 64, Issue:8 Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control Studies; Female; Flecainide; Heart Failure; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Sotalol	2010
Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement? Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011, Volume: 13, Issue:3 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Evidence-Based Medicine; Flecainide; Humans; Propafenone; Sotalol; Treatment Outcome	2011
Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation, 2011, Oct-18, Volume: 124, Issue:16 Topics: Anti-Arrhythmia Agents; Digoxin; Drug Evaluation; Female; Fetal Diseases; Fetal Therapies; Flecainide; Humans; Pregnancy; Retrospective Studies; Sotalol; Tachycardia, Supraventricular; Treatment Outcome	2011
[Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs]. Medicina clinica, 2013, Apr-20, Volume: 140, Issue:8 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Body Mass Index; Comorbidity; Diabetes Mellitus; Female; Flecainide; Heart Rate; Heart Valve Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Prognosis; Propafenone; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Remission Induction; Sotalol; Time Factors; Treatment Outcome	2013
Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2013, Volume: 15, Issue:5 Topics: Acetanilides; Administration, Oral; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Flecainide; Heart Conduction System; Heart Rate; In Vitro Techniques; Neural Conduction; Piperazines; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Sodium Channel Blockers; Sotalol; Treatment Outcome	2013
Resting heart rate and physical activity as risk factors for lone atrial fibrillation: a prospective study of 309,540 men and women. Heart (British Cardiac Society), 2013, Volume: 99, Issue:23 Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Early Diagnosis; Exercise; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Sotalol	2013
Combination drug therapy for patients with intractable ventricular tachycardia associated with right ventricular cardiomyopathy. Pacing and clinical electrophysiology : PACE, 2014, Volume: 37, Issue:1 Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Chronic Disease; Drug Therapy, Combination; Female; Flecainide; Humans; Male; Mexiletine; Retrospective Studies; Sotalol; Tachycardia, Ventricular; Treatment Failure; Treatment Outcome	2014
Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease. The American journal of cardiology, 2015, Feb-01, Volume: 115, Issue:3 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Databases, Factual; Dronedarone; Drug Substitution; Female; Flecainide; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Propafenone; Sotalol	2015
Evaluation of Index of Cardio-Electrophysiological Balance (iCEB) as a New Biomarker for the Identification of Patients at Increased Arrhythmic Risk. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2016, Volume: 21, Issue:3 Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biomarkers, Pharmacological; Brugada Syndrome; Dose-Response Relationship, Drug; Electrocardiography; Female; Flecainide; Humans; Long QT Syndrome; Male; Retrospective Studies; Risk Assessment; Sotalol	2016
The evolving landscape of oral anti-arrhythmic prescriptions for atrial fibrillation in England: 1998-2014. European heart journal. Cardiovascular pharmacotherapy, 2016, Volume: 2, Issue:2 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Drug Prescriptions; Drug Utilization; England; Flecainide; Humans; Retrospective Studies; Sotalol	2016
Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy. Heart rhythm, 2017, Volume: 14, Issue:4 Topics: Adult; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Catheter Ablation; Combined Modality Therapy; Drug Monitoring; Drug Therapy, Combination; Electrophysiologic Techniques, Cardiac; Female; Flecainide; Humans; Male; Metoprolol; Middle Aged; Recurrence; Sotalol; Treatment Outcome	2017
Antenatal antiarrhythmic treatment for fetal tachyarrhythmias: a study protocol for a prospective multicentre trial. BMJ open, 2017, Aug-29, Volume: 7, Issue:8 Topics: Anti-Arrhythmia Agents; Atrial Flutter; Child Development; Child, Preschool; Digoxin; Drug Therapy, Combination; Echocardiography, Doppler; Female; Fetal Death; Fetal Diseases; Flecainide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Japan; Male; Pregnancy; Prenatal Care; Prospective Studies; Research Design; Sotalol; Tachycardia, Supraventricular	2017
Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics. Clinical therapeutics, 2018, Volume: 40, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Databases, Factual; Dronedarone; Female; Flecainide; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Propafenone; Retrospective Studies; Sotalol	2018
Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs. American heart journal, 2018, Volume: 205 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cause of Death; Dronedarone; Female; Flecainide; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Sotalol; Survival Rate; Sweden; Tachycardia, Ventricular	2018
Combined flecainide and sotalol therapy for multifocal atrial tachycardia in cardio-facio-cutaneous syndrome. Pediatrics international : official journal of the Japan Pediatric Society, 2018, Volume: 60, Issue:11 Topics: Anti-Arrhythmia Agents; Drug Therapy, Combination; Ectodermal Dysplasia; Electrocardiography; Facies; Failure to Thrive; Flecainide; Heart Defects, Congenital; Humans; Infant, Newborn; Male; Sotalol; Tachycardia; Treatment Outcome	2018
Telemetered common marmosets is useful for the assessment of electrocardiogram parameters changes induced by multiple cardiac ion channel inhibitors. The Journal of toxicological sciences, 2019, Volume: 44, Issue:7 Topics: Animals; Astemizole; Body Temperature; Calcium Channel Blockers; Callithrix; Electrocardiography; Flecainide; Male; Models, Animal; Quinidine; Risk Assessment; Sotalol; Telemetry; Terfenadine; Verapamil; Voltage-Gated Sodium Channel Blockers	2019
High-throughput quantification of ten antiarrhythmic drugs in human plasma using UPLC-MS/MS. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2019, Oct-15, Volume: 1129 Topics: Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carvedilol; Chromatography, High Pressure Liquid; Diltiazem; Flecainide; High-Throughput Screening Assays; Humans; Lidocaine; Metoprolol; Propranolol; Reproducibility of Results; Sotalol; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Verapamil	2019
Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs. JAMA cardiology, 2020, 01-01, Volume: 5, Issue:1 Topics: Aged; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Diet, High-Fat; Disease Models, Animal; Female; Flecainide; Heart; Humans; Logistic Models; Male; Mice; Middle Aged; Multivariate Analysis; NAV1.5 Voltage-Gated Sodium Channel; Obesity; Sex Factors; Sotalol; Treatment Failure; Treatment Outcome; Voltage-Gated Sodium Channel Blockers	2020
How to differentiate second-degree atrioventricular block from extrasystoles in fetuses with a bigeminal ventricular rhythm. Acta obstetricia et gynecologica Scandinavica, 2020, Volume: 99, Issue:9 Topics: Atrioventricular Block; Cardiac Complexes, Premature; Digoxin; Female; Fetus; Flecainide; Humans; Pregnancy; Sotalol; Tachycardia	2020
The Efficacy of Anti-Arrhythmic Drugs in Children With Idiopathic Frequent Symptomatic or Asymptomatic Premature Ventricular Complexes With or Without Asymptomatic Ventricular Tachycardia: a Retrospective Multi-Center Study. Pediatric cardiology, 2021, Volume: 42, Issue:4 Topics: Adolescent; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Flecainide; Humans; Male; Retrospective Studies; Sotalol; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes; Verapamil	2021
Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre. BMC cardiovascular disorders, 2021, 03-15, Volume: 21, Issue:1 Topics: Action Potentials; Adrenergic beta-Antagonists; Age Factors; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Female; Flecainide; Heart Rate; Humans; Infant; Infant, Newborn; Male; Nadolol; Recurrence; Retrospective Studies; Sotalol; Tachycardia, Supraventricular; Time Factors; Treatment Outcome; Voltage-Gated Sodium Channel Blockers	2021
Limited duration of antiarrhythmic drug use for newly diagnosed atrial fibrillation in a nationwide population under age 65. Journal of cardiovascular electrophysiology, 2021, Volume: 32, Issue:6 Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Flecainide; Humans; Male; Middle Aged; Sotalol; Treatment Outcome; Young Adult	2021
"Second line medications" for supraventricular arrhythmias in children: In-hospital efficacy and adverse events during treatment initiation of sotalol and flecainide. Journal of cardiovascular electrophysiology, 2021, Volume: 32, Issue:8 Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Flecainide; Hospitals; Humans; Sotalol	2021
Safety and efficacy of flecainide associated with beta-blockers in arrhythmogenic right ventricular cardiomyopathy. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2022, 02-02, Volume: 24, Issue:2 Topics: Arrhythmogenic Right Ventricular Dysplasia; Atrial Fibrillation; Defibrillators, Implantable; Flecainide; Humans; Retrospective Studies; Sotalol; Tachycardia, Ventricular; Treatment Outcome	2022
Pharmacological characterisation of electrocardiogram J-T European journal of pharmacology, 2022, Jul-15, Volume: 927 Topics: Animals; DNA-Binding Proteins; Electrocardiography; Flecainide; Guinea Pigs; Long QT Syndrome; Nifedipine; Quinidine; Quinine; Ranolazine; Sotalol; Torsades de Pointes; Verapamil	2022
The Feasibility and Safety of Flecainide Use Among Patients With Varying Degrees of Coronary Disease. JACC. Clinical electrophysiology, 2023, Volume: 9, Issue:7 Pt 2 Topics: Coronary Artery Disease; Feasibility Studies; Flecainide; Humans; Retrospective Studies; Sotalol; Tachycardia, Ventricular	2023
Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation : A Retrospective Cohort Study. Annals of internal medicine, 2023, Volume: 176, Issue:6 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Female; Flecainide; Hemorrhage; Hospitalization; Humans; Ischemic Stroke; Male; Medicare; Retrospective Studies; Rivaroxaban; Sotalol; Stroke; United States	2023
Idiopathic premature ventricular complexes treatment: Comparison of flecainide, propafenone, and sotalol. Clinical cardiology, 2023, Volume: 46, Issue:10 Topics: Anti-Arrhythmia Agents; Electrocardiography; Flecainide; Humans; Propafenone; Retrospective Studies; Sotalol; Ventricular Premature Complexes	2023